Miller CM - Search Results

1

Expression of GMP-140 (P-selectin) correlates with graft viability in cold-preserved rat livers.

Basile J, Wang L, Tarcsafalvi A, Han R, Boros P, Miller CM. Basile J, et al. Among authors: miller cm. Transplantation. 2000 Jun 15;69(11):2440-2. doi: 10.1097/00007890-200006150-00039. Transplantation. 2000. PMID: 10868655

2

The splenic artery as the inflow in arterial revascularization of the liver graft in clinical liver transplantation.

Katz E, Fukuzawa K, Schwartz M, Mor E, Miller C. Katz E, et al. Transplantation. 1992 Jun;53(6):1373-4. Transplantation. 1992. PMID: 1376505 No abstract available.

3

Evidence that the systematic analysis of bile cytology permits monitoring of hepatic allograft rejection.

Roberti I, Lieberman KV, Manzarbeitia C, Schwartz M, Reisman L, Miller C. Roberti I, et al. Transplantation. 1992 Sep;54(3):471-4. doi: 10.1097/00007890-199209000-00017. Transplantation. 1992. PMID: 1384182

4

Accessory right hepatic duct stricture following liver transplantation.

Manzarbeitia C, Schwartz ME, Train JS, Miller CM. Manzarbeitia C, et al. Among authors: miller cm. Transplantation. 1991 Sep;52(3):556-8. Transplantation. 1991. PMID: 1897031 No abstract available.

5

Initial flush solution for donor liver procurement: lactated Ringers' or UW solution? A randomized, prospective trial.

Schwartz ME, Nishizaki T, Thung SN, Manzarbeitia C, Maharajh A, Gordon R, Miller CM. Schwartz ME, et al. Among authors: miller cm. Transplant Proc. 1991 Feb;23(1 Pt 2):1554-6. Transplant Proc. 1991. PMID: 1989287 Clinical Trial. No abstract available.

6

Resistant hepatic allograft rejection successfully treated with cyclophosphamide and plasmapheresis.

Evrard HM, Miller C, Schwartz M, Thung SN, Mayer L. Evrard HM, et al. Transplantation. 1990 Oct;50(4):702-4. doi: 10.1097/00007890-199010000-00033. Transplantation. 1990. PMID: 2219293 No abstract available.

7

FK506 versus cyclosporine as primary immunosuppressive agent for orthotopic liver allograft recipients. Histologic and immunopathologic observations.

Hytiroglou P, Lee R, Sharma K, Theise ND, Schwartz M, Miller C, Thung SN. Hytiroglou P, et al. Transplantation. 1993 Dec;56(6):1389-94. doi: 10.1097/00007890-199312000-00022. Transplantation. 1993. PMID: 7506452 Clinical Trial.

8

Therapy with FK 506 in pediatric liver recipients.

Rosh JR, Schwersenz AH, Schwartz M, Moran V, Leleiko N, LeLeiko VM, Miller CM. Rosh JR, et al. Among authors: miller cm. Transplant Proc. 1994 Feb;26(1):152-3. Transplant Proc. 1994. PMID: 7509091 Clinical Trial. No abstract available.

9

Reversal of gastrointestinal toxicity associated with long-term FK506 immunosuppression by conversion to cyclosporine in liver transplant recipients.

Mor E, Schwersenz A, Sheiner PA, Emre S, Schwartz ME, Miller CM. Mor E, et al. Among authors: miller cm. Transplantation. 1994 Apr 15;57(7):1130-2. Transplantation. 1994. PMID: 7513098 No abstract available.

10

Acute renal failure associated with the use of ibuprofen in two liver transplant recipients on FK506.

Sheiner PA, Mor E, Chodoff L, Glabman S, Emre S, Schwartz ME, Miller CM. Sheiner PA, et al. Among authors: miller cm. Transplantation. 1994 Apr 15;57(7):1132-3. Transplantation. 1994. PMID: 7513099 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

546 results

Search Page

Filters